Data / Form D filings / Santa Ana Bio, Inc.
Santa Ana Bio, Inc.: Form D filings
Santa Ana Bio, Inc., a biotechnology company in Alameda, CA, filed 3 Form D notices with the SEC between 2021 and 2024. The latest, on June 17, 2024, reports $20 million sold of a $125 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1105 Atlantic Ave., Suite 104, Alameda, CA, 94501
- Phone
- (858) 705-2660
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1864492
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2024 | New notice | $125,000,000 | $19,999,998 | $105,000,002 | 10 | May 16, 2024 | sec.gov |
| Feb 28, 2023 | New notice | $70,313,642 | $35,313,642 | $35,000,000 | 5 | Feb 14, 2023 | sec.gov |
| Jun 1, 2021 | New notice | $42,024,657 | $8,024,658 | $33,999,999 | 1 | May 17, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mittie Doyle | Director | |
| Peter Emtage | Executive Officer, Director | |
| Jerel Davis | Director | |
| Shinichiro Fuse | Director | |
| Brendan Bulik-Sullivan | Director | |
| Christine Borowski | Director | |
| Marcelo Bigalo | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jun 17, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Santa Ana Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.